| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.3 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.032 | 0.3 |